BOSTON--(BUSINESS WIRE)--John Serafini, Senior Vice President of Allied Minds (LSE: ALM), a diversified holding company focused on venture creation within the life science and technology sectors, will be participating in the “Spin In and Spin Out — Challenges & Opportunities for Disruptive Technology Commercialization” panel discussion at the conference of the National Defense Industrial Association New England Chapter (ndianewengland.org) in Lowell, Massachusetts on June 16, 2016. Serafini will be discussing best practices, challenges, and opportunities for national research laboratories and corporate/venture funds to partner to commercialize federally funded innovations.
The conference focus is “Advancing National Security Innovation: Fostering DoD/New England Industry Collaboration” and brings together national security innovation communities. The event features speakers from the U.S. Department of Defense (DoD), federal and state agencies, defense contractors, research laboratories, higher education, industry, and the financial sector. It aims to highlight innovation technology industries with significant DoD and industry interests to explore the challenges and opportunities for collaboration.
“As a Boston-based company, Allied Minds is committed to supporting New England’s efforts to extend the innovation economy to include the national security arena,” Serafini said. “Allied Minds offers an institutional platform for taking intellectual property from university or federal research settings and transforming these inventions into product-based companies.”
Charlie Benway, director of the MITRE/Massachusetts Innovation Bridge, will moderate the “Spin In and Spin Out” panel. In addition to Serafini, the panel will feature speakers from New Technology Ventures, Battelle Memorial Institute, The MITRE Corporation, and MIT Lincoln Laboratories.
More information about Boston-based Allied Minds can be found at www.alliedminds.com.
About Allied Minds
Allied Minds (LSE: ALM) is a diversified
holding company focused on venture creation within the life science and
technology sectors. With unparalleled access to hundreds of university
and federal labs across the U.S., Allied Minds forms, funds, and
operates a portfolio of companies to generate long-term value for its
investors and stakeholders. Based in Boston, with offices in Los Angeles
and New York, Allied Minds supports its businesses with capital, central
management, and shared services. For more information, please visit www.alliedminds.com.
Allied Minds Forward-Looking Statement
This press
release contains statements that are or may be forward-looking
statements, including statements that relate to the company’s future
prospects, developments and strategies. The forward-looking statements
are based on current expectations and are subject to known and unknown
risks and uncertainties that could cause actual results, performance and
achievements to differ materially from current expectations, including,
but not limited to, those risk and uncertainties described in the risk
factors included in the company’s regulatory filings. These
forward-looking statements are based on assumptions regarding the
present and future business strategies of the company and the
environment in which it will operate in the future. Each forward-looking
statement speaks only as at the date of this press release. Except as
required by law, regulatory requirement, the Listing Rules and the
Disclosure and Transparency Rules, neither the company nor any other
party intends to update or revise these forward-looking statements,
whether as a result of new information, future events or otherwise
